How the Drug Discovery Industry Works
We are traveling to Manchester for our next BioLearn in-person course, which is kindly being hosted by Citylabs 1.0, Europe's largest academic campus.
This course is predominantly aimed at non-scientists working within the Life Sciences industry in non-research roles, and is relevant for employees who are new to the industry or who have more established professional dealings within it.
In short, the course will focus on the structure and commercial environment of the biopharmaceutical industry and highlights the processes required to move a drug candidate from the discovery laboratory through to the marketplace.
If you work within a research role, this course will help you to become more attuned to the commercial environment of the Life Sciences industry, but please be aware that there will an element of crossover with your existing knowledge.
The Commercial Landscape
- Global pharmaceutical sales
- Market breakdown
- Pharma companies
- Products
Human Biology, Pathology & Drug Targets
- The burden of disease
- Levels of complexity
- Drug-target interactions
- Pharmacology concepts
- Different types of drug molecule
Drug Discovery & Development
- Organisation of drug discovery
- Development, screening & clinical trial processes
- Regulatory agencies
- Pharmacovigilance & safety
Industry Pressures & Responses
- Growth of biologicals
- New drug development companies
Industry in Transition
- Rare diseases
- Personalised medicines
This course will be delivered on Thursday 19th January 2022 between 12:00-17:00 LIVE in person. Course materials are included in the course costs.
